Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 Mar;63(3):541–548.

Interleukin 2 activity in chronic liver disease and the effect of in vitro alpha-interferon.

S Saxena, K T Nouri-Aria, M G Anderson, A L Eddleston, R Williams
PMCID: PMC1577566  PMID: 3486732

Abstract

To investigate mitogen induced helper interleukin 2 (IL-2) production in patients with chronic liver disease (CLD), IL-2 activity was assessed by an IL-2 bioassay using phytohaemagglutinin (PHA)-stimulated peripheral blood mononuclear cells (PBMNC). IL-2 activity was significantly reduced in patients with autoimmune chronic active hepatitis, primary biliary cirrhosis and alcoholic hepatitis with or without cirrhosis (P less than 0.01), and was comparable to controls in those with alcoholic cirrhosis alone. In vitro preincubation of PBMNC with lymphoblastoid alpha-interferon (alpha-IFN) before stimulation with PHA, led to a significant increase in IL-2 activity in all subjects (P less than 0.01), except those with alcoholic hepatitis, but in none of the groups did the levels of IL-2 activity reach those seen in normal subjects. The decrease in IL-2 activity in patients with CLD may be due to low IL-2 production or presence of an IL-2 antagonist(s). Such an abnormality may occur, not only as a result of liver damage, but may also be important in determining immunological disturbances involved in the pathogenesis of the liver disease.

Full text

PDF
543

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Actis G., Mieli-Vergani G., Portmann B., Eddleston A. L., Davis M., Williams R. Lymphocyte cytotoxicity to autologous hepatocytes in alcoholic liver disease. Liver. 1983 Feb;3(1):8–12. doi: 10.1111/j.1600-0676.1983.tb00844.x. [DOI] [PubMed] [Google Scholar]
  2. Gillis S., Smith K. A. Long term culture of tumour-specific cytotoxic T cells. Nature. 1977 Jul 14;268(5616):154–156. doi: 10.1038/268154a0. [DOI] [PubMed] [Google Scholar]
  3. Gillis S., Smith K. A., Watson J. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines. J Immunol. 1980 Apr;124(4):1954–1962. [PubMed] [Google Scholar]
  4. Johnson H. M., Farrar W. L. The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptors. Cell Immunol. 1983 Jan;75(1):154–159. doi: 10.1016/0008-8749(83)90314-3. [DOI] [PubMed] [Google Scholar]
  5. Kakumu S., Yata K., Kashio T. Immunoregulatory T-cell function in acute and chronic liver disease. Gastroenterology. 1980 Oct;79(4):613–619. [PubMed] [Google Scholar]
  6. Karttunen R., Nurmi T., Ilonen J., Surcel H. M. Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets. Clin Exp Immunol. 1984 Feb;55(2):257–263. [PMC free article] [PubMed] [Google Scholar]
  7. Linker-Israeli M., Bakke A. C., Kitridou R. C., Gendler S., Gillis S., Horwitz D. A. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol. 1983 Jun;130(6):2651–2655. [PubMed] [Google Scholar]
  8. McPherson K., Wennberg J. E., Hovind O. B., Clifford P. Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. N Engl J Med. 1982 Nov 18;307(21):1310–1314. doi: 10.1056/NEJM198211183072104. [DOI] [PubMed] [Google Scholar]
  9. Miyawaki T., Seki H., Taga K., Sato H., Taniguchi N. Dissociated production of interleukin-2 and immune (gamma) interferon by phytohaemagglutinin stimulated lymphocytes in healthy infants. Clin Exp Immunol. 1985 Feb;59(2):505–511. [PMC free article] [PubMed] [Google Scholar]
  10. Mogensen C. E. The glomerular permeability determined by dextran clearance using Sephadex gel filtration. Scand J Clin Lab Invest. 1968;21(1):77–82. doi: 10.3109/00365516809076979. [DOI] [PubMed] [Google Scholar]
  11. Morgan D. A., Ruscetti F. W., Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science. 1976 Sep 10;193(4257):1007–1008. doi: 10.1126/science.181845. [DOI] [PubMed] [Google Scholar]
  12. Nakayama E., Asano S., Takuwa N., Yokota J., Miwa S. Decreased TCGF activity in the culture medium of PHA stimulated peripheral mononuclear cells from patients with metastatic cancer. Clin Exp Immunol. 1983 Mar;51(3):511–516. [PMC free article] [PubMed] [Google Scholar]
  13. Nouri A. M., Panayi G. S., Goodman S. M. Cytokines and the chronic inflammation of rheumatic disease. II. The presence of interleukin-2 in synovial fluids. Clin Exp Immunol. 1984 Nov;58(2):402–409. [PMC free article] [PubMed] [Google Scholar]
  14. Saxena S., Nouri-Aria K. T., Anderson M. G., Williams R., Eddleston A. L. In vitro alpha-interferon treatment of peripheral blood mononuclear cells improves interleukin-2 activity in HBV-related chronic liver disease. J Hepatol. 1985;1(4):385–393. doi: 10.1016/s0168-8278(85)80776-5. [DOI] [PubMed] [Google Scholar]
  15. Smith K. A. T-cell growth factor. Immunol Rev. 1980;51:337–357. doi: 10.1111/j.1600-065x.1980.tb00327.x. [DOI] [PubMed] [Google Scholar]
  16. Snyder N., Bessoff J., Dwyer J. M., Conn H. O. Depressed delayed cutaneous hypersensitivity in alcoholic hepatitis. Am J Dig Dis. 1978 Apr;23(4):353–358. doi: 10.1007/BF01072420. [DOI] [PubMed] [Google Scholar]
  17. Tilden A. B., Balch C. M. A comparison of PGE2 effects on human suppressor cell function and on interleukin 2 function. J Immunol. 1982 Dec;129(6):2469–2473. [PubMed] [Google Scholar]
  18. Vergani G. M., Vergani D., Jenkins P. J., Portmann B., Mowat A. P., Eddleston A. L., Williams R. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. Clin Exp Immunol. 1979 Oct;38(1):16–21. [PMC free article] [PubMed] [Google Scholar]
  19. Watson J., Gillis S., Marbrook J., Mochizuki D., Smith K. A. Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines. J Exp Med. 1979 Oct 1;150(4):849–861. doi: 10.1084/jem.150.4.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Yoshioka K., Kakumu S., Murakami H., Fukui K. Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction. Clin Exp Immunol. 1984 Jun;56(3):669–676. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES